56.28 USD
-0.87 (-1.52%)
We assign a fundamental rating of 6 out of 10 to UTMD. UTMD was compared to 186 industry peers in the Health Care Equipment & Supplies industry. UTMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. UTMD is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
UTMD had positive earnings in the past year.
UTMD had a positive operating cash flow in the past year.
In the past 5 years UTMD has always been profitable.
UTMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
UTMD has a Return On Assets of 9.53%. This is amongst the best in the industry. UTMD outperforms 92.47% of its industry peers.
UTMD has a better Return On Equity (9.83%) than 86.56% of its industry peers.
UTMD has a Return On Invested Capital of 8.26%. This is amongst the best in the industry. UTMD outperforms 84.95% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for UTMD is above the industry average of 8.84%.
The 3 year average ROIC (12.32%) for UTMD is well above the current ROIC(8.26%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.53% | ||
| ROE | 9.83% | ||
| ROIC | 8.26% |
ROA(3y)12.3%
ROA(5y)11.87%
ROE(3y)13.06%
ROE(5y)12.7%
ROIC(3y)12.32%
ROIC(5y)12.29%
1.3 Margins
UTMD has a better Profit Margin (30.08%) than 97.31% of its industry peers.
In the last couple of years the Profit Margin of UTMD has grown nicely.
Looking at the Operating Margin, with a value of 30.78%, UTMD belongs to the top of the industry, outperforming 97.85% of the companies in the same industry.
UTMD's Operating Margin has been stable in the last couple of years.
The Gross Margin of UTMD (57.10%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of UTMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.78% | ||
| PM (TTM) | 30.08% | ||
| GM | 57.1% |
OM growth 3Y-0.06%
OM growth 5Y0.46%
PM growth 3Y4%
PM growth 5Y1.55%
GM growth 3Y-2.17%
GM growth 5Y-1.24%
2. Health
2.1 Basic Checks
UTMD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, UTMD has less shares outstanding
Compared to 5 years ago, UTMD has less shares outstanding
UTMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
UTMD has an Altman-Z score of 32.05. This indicates that UTMD is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 32.05, UTMD belongs to the best of the industry, outperforming 98.39% of the companies in the same industry.
UTMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 32.05 |
ROIC/WACC0.94
WACC8.76%
2.3 Liquidity
UTMD has a Current Ratio of 32.06. This indicates that UTMD is financially healthy and has no problem in meeting its short term obligations.
UTMD has a better Current ratio (32.06) than 99.46% of its industry peers.
A Quick Ratio of 29.36 indicates that UTMD has no problem at all paying its short term obligations.
UTMD has a Quick ratio of 29.36. This is amongst the best in the industry. UTMD outperforms 99.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 32.06 | ||
| Quick Ratio | 29.36 |
3. Growth
3.1 Past
The earnings per share for UTMD have decreased strongly by -17.30% in the last year.
The Earnings Per Share has been growing slightly by 0.16% on average over the past years.
Looking at the last year, UTMD shows a very negative growth in Revenue. The Revenue has decreased by -12.35% in the last year.
UTMD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.70% yearly.
EPS 1Y (TTM)-17.3%
EPS 3Y-0.66%
EPS 5Y0.16%
EPS Q2Q%-19.91%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-5.87%
Revenue growth 5Y-2.7%
Sales Q2Q%-1.93%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.90, which indicates a correct valuation of UTMD.
Based on the Price/Earnings ratio, UTMD is valued cheaply inside the industry as 87.63% of the companies are valued more expensively.
UTMD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.9 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UTMD is valued cheaper than 96.77% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of UTMD indicates a rather cheap valuation: UTMD is cheaper than 95.16% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.97 | ||
| EV/EBITDA | 6.47 |
4.3 Compensation for Growth
UTMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)102.41
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
UTMD has a Yearly Dividend Yield of 2.20%.
UTMD's Dividend Yield is rather good when compared to the industry average which is at 0.20. UTMD pays more dividend than 97.31% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, UTMD has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.2% |
5.2 History
The dividend of UTMD has a limited annual growth rate of 1.95%.
UTMD has been paying a dividend for at least 10 years, so it has a reliable track record.
UTMD has decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.95%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
34.80% of the earnings are spent on dividend by UTMD. This is a low number and sustainable payout ratio.
The dividend of UTMD is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP34.8%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:UTMD (12/30/2025, 8:00:02 PM)
56.28
-0.87 (-1.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners70.37%
Inst Owner Change0.42%
Ins Owners7.14%
Ins Owner Change-0.27%
Market Cap180.10M
Revenue(TTM)38.63M
Net Income(TTM)11.62M
Analysts0
Price TargetN/A
Short Float %3.32%
Short Ratio7.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.2% |
Yearly Dividend1.22
Dividend Growth(5Y)1.95%
DP34.8%
Div Incr Years2
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.9 | ||
| Fwd PE | N/A | ||
| P/S | 4.66 | ||
| P/FCF | 12.97 | ||
| P/OCF | 12.73 | ||
| P/B | 1.52 | ||
| P/tB | 1.75 | ||
| EV/EBITDA | 6.47 |
EPS(TTM)3.54
EY6.29%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.34
FCFY7.71%
OCF(TTM)4.42
OCFY7.86%
SpS12.07
BVpS36.95
TBVpS32.13
PEG (NY)N/A
PEG (5Y)102.41
Graham Number54.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.53% | ||
| ROE | 9.83% | ||
| ROCE | 9.99% | ||
| ROIC | 8.26% | ||
| ROICexc | 28.34% | ||
| ROICexgc | 51.06% | ||
| OM | 30.78% | ||
| PM (TTM) | 30.08% | ||
| GM | 57.1% | ||
| FCFM | 35.93% |
ROA(3y)12.3%
ROA(5y)11.87%
ROE(3y)13.06%
ROE(5y)12.7%
ROIC(3y)12.32%
ROIC(5y)12.29%
ROICexc(3y)38.7%
ROICexc(5y)33.39%
ROICexgc(3y)78.49%
ROICexgc(5y)75.65%
ROCE(3y)14.9%
ROCE(5y)14.86%
ROICexgc growth 3Y-5.7%
ROICexgc growth 5Y-2.21%
ROICexc growth 3Y5.77%
ROICexc growth 5Y9.65%
OM growth 3Y-0.06%
OM growth 5Y0.46%
PM growth 3Y4%
PM growth 5Y1.55%
GM growth 3Y-2.17%
GM growth 5Y-1.24%
F-Score6
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 9.27% | ||
| Cap/Sales | 0.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 95.53% | ||
| Profit Quality | 119.44% | ||
| Current Ratio | 32.06 | ||
| Quick Ratio | 29.36 | ||
| Altman-Z | 32.05 |
F-Score6
WACC8.76%
ROIC/WACC0.94
Cap/Depr(3y)10.06%
Cap/Depr(5y)9.94%
Cap/Sales(3y)1.14%
Cap/Sales(5y)1.32%
Profit Quality(3y)119.58%
Profit Quality(5y)135.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-17.3%
EPS 3Y-0.66%
EPS 5Y0.16%
EPS Q2Q%-19.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-5.87%
Revenue growth 5Y-2.7%
Sales Q2Q%-1.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.61%
EBIT growth 3Y-5.93%
EBIT growth 5Y-2.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.02%
FCF growth 3Y-10.92%
FCF growth 5YN/A
OCF growth 1Y-37.46%
OCF growth 3Y-11.23%
OCF growth 5Y-2.76%
UTAH MEDICAL PRODUCTS INC / UTMD FAQ
What is the ChartMill fundamental rating of UTAH MEDICAL PRODUCTS INC (UTMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to UTMD.
What is the valuation status for UTMD stock?
ChartMill assigns a valuation rating of 5 / 10 to UTAH MEDICAL PRODUCTS INC (UTMD). This can be considered as Fairly Valued.
Can you provide the profitability details for UTAH MEDICAL PRODUCTS INC?
UTAH MEDICAL PRODUCTS INC (UTMD) has a profitability rating of 8 / 10.
What is the valuation of UTAH MEDICAL PRODUCTS INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for UTAH MEDICAL PRODUCTS INC (UTMD) is 15.9 and the Price/Book (PB) ratio is 1.52.